TALIANO, Marina
 Distribuzione geografica
Continente #
NA - Nord America 390
EU - Europa 179
AS - Asia 135
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 710
Nazione #
US - Stati Uniti d'America 389
CN - Cina 67
SG - Singapore 39
IT - Italia 37
SE - Svezia 30
IE - Irlanda 23
UA - Ucraina 21
DE - Germania 18
FI - Finlandia 13
KR - Corea 12
FR - Francia 11
AT - Austria 9
IN - India 6
PL - Polonia 5
GB - Regno Unito 4
VN - Vietnam 4
AU - Australia 3
BE - Belgio 3
NL - Olanda 3
PH - Filippine 3
EU - Europa 2
HK - Hong Kong 2
CA - Canada 1
ES - Italia 1
ID - Indonesia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 710
Città #
Chandler 54
Singapore 36
Beijing 35
Houston 29
Fairfield 27
Ann Arbor 23
Ashburn 23
Dublin 23
Jacksonville 16
Santa Clara 16
Nyköping 14
Dearborn 12
Torino 11
Vienna 9
Fremont 8
Seattle 8
Shanghai 8
Woodbridge 8
Columbus 7
Munich 7
Princeton 7
Wilmington 7
Boston 6
Cambridge 6
Hangzhou 5
Medford 5
Boardman 4
Pisa 4
San Mateo 4
Turin 4
Villeurbanne 4
Brussels 3
Iowa City 3
Chengdu 2
Dong Ket 2
Guangzhou 2
Milan 2
Nanjing 2
Poznan 2
Pune 2
Rome 2
San Diego 2
Utrecht 2
Warsaw 2
Zhengzhou 2
Bratislava 1
Canberra 1
Central 1
Chongqing 1
Falls Church 1
Harbin 1
Helsinki 1
Jakarta 1
Kunming 1
Leiden 1
Los Angeles 1
Madrid 1
Melbourne 1
Miami 1
New York 1
Parma 1
Phoenix 1
Quanzhou 1
Redmond 1
San Jose 1
Sydney 1
Toronto 1
Upper Marlboro 1
Washington 1
Xian 1
Zhongxin 1
Totale 486
Nome #
Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure 251
Obestatin promotes glut-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 104
Obestatin promotes GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes and inhibits lipolysis in 3T3-L1 and human visceral and subcutaneous adipocytes 88
Age-related endocrine and metabolic changes in simple obesity. 81
Modification of hormonal and seminal parameters during HCV infection treatment. 71
Two years follow up of hormonal and seminal parameters in patients with testicular neoplasia or lymphoproliferative disorders. 67
Alterations of spermatogenetic parameters in HCV infection before and during antiviral treatment. 67
Totale 729
Categoria #
all - tutte 2.110
article - articoli 0
book - libri 0
conference - conferenze 1.296
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 5 26 13 8 12 8 10 4
2020/202188 11 6 5 2 14 3 6 7 4 13 11 6
2021/202289 0 4 1 7 9 4 6 5 1 5 29 18
2022/2023152 11 16 5 16 13 32 7 15 22 6 6 3
2023/202454 6 12 4 1 3 7 0 8 0 0 6 7
2024/202568 0 17 3 15 33 0 0 0 0 0 0 0
Totale 729